Synthace Named a 2018 Cool Vendor in Life Sciences by Gartner
Recognised by Leading Analyst Firm for its Laboratory of the Future Platform LONDON 19 June 2018…
read moreSynthace is a revenue generating biotech and software company supplying tools and services to optimise bio manufacturing for blue chip clients across all industry sectors. Core to Synthace’s success is its Antha biology operating system that improves bioengineering productivity by connecting hardware and protocols across the laboratory to dramatically improve experimental efficiency.
Status current
Associated Fund UK Innovation & Science Seed Fund
Sector Medical / Biotechnology
Website www.synthace.com
Recognised by Leading Analyst Firm for its Laboratory of the Future Platform LONDON 19 June 2018…
read moreSynthace Ltd., a London based technology company developing Antha, a high level language and operating…
read moreSynthace and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE:DOW), today…
read moreSynthace London-based Synthace provides next-generation software and processes to exponentially improve productivity in bioscience, enabling…
read more